Cora Health vs Pomegranate Health for Compounded GLP-1: 2026 Comparison of Pricing, Pharmacy Choice, and Total Monthly Cost

Cora Health vs Pomegranate Health: the short answer

Cora Health and Pomegranate Health both compete in the no-membership-fee compounded GLP-1 telehealth segment. Both are positioned around pricing transparency and patient-friendly billing structures. The substantive differences are pricing structure, pharmacy partnership model, and state coverage. Cora Health's annual Essential Plan is $99/month all-inclusive for compounded semaglutide vs Pomegranate's $119/month for compounded semaglutide with B12 vitamin. For compounded tirzepatide, Cora's annual Premium Plan is $135/month vs Pomegranate's $179/month for tirzepatide with B6 vitamin. Pomegranate uses a $75 upfront consultation fee model (credited toward first medication) rather than a subscription. Cora publicly names VialsRx as its single 503A compounding pharmacy partner; Pomegranate discloses multiple pharmacy partners (Hallandale, Empower, OptioRx) and lets patients choose. Cora serves all 50 states; Pomegranate is not available in California, Iowa, or Wisconsin.

Quick comparison at a glance

All numbers reflect publicly stated pricing as of May 2026. Pomegranate's pricing includes B-vitamin additives. Individual experiences vary.

Pricing: subscription vs pay-per-service, with similar headline rates

Both platforms have abandoned the monthly membership fee that characterizes Hims, Lemonaid, Mochi, and other major competitors. The differences are in pricing structure and B-vitamin additives.

Cora Health Essential Plan (compounded semaglutide): - Annual: $99/month ($1,188 billed once) - 6-month: $120/month ($720 billed once) - 3-month: $145/month ($435 billed once) - Monthly: $175/month

Cora Health Premium Plan (compounded tirzepatide): - Annual: $135/month ($1,620 billed once) - 6-month: $175/month - 3-month: $199/month - Monthly: $225/month

Pomegranate Health compounded semaglutide (with B12 cyanocobalamin): - Starting at $119/month for starter dose through Hallandale, Empower, or OptioRx pharmacy partners - Bundle discounts apply for 3-month and 6-month plans - $75 upfront consultation fee (credited toward first medication purchase) - Pay-per-service: patient orders refills as needed; no automatic subscription

Pomegranate Health compounded tirzepatide (with B6 pyridoxine): - Starting at $179/month - Bundle discounts apply for 3-month and 6-month plans - $75 consultation fee at intake and $75 for refill consultations

For a cash-pay patient on a 12-month treatment course on compounded semaglutide: - Cora annual plan: $1,188/year (one upfront charge) - Pomegranate at $119/month × 12 = $1,428/year plus $75 initial consultation + any refill consultation fees = ~$1,500-$1,800/year depending on how many refill consultations are needed

For compounded tirzepatide: - Cora annual plan: $1,620/year - Pomegranate at $179/month × 12 = $2,148/year plus consultation fees

The key trade-off: Pomegranate's $75 refill consultation fee on each reorder can add up for long-term patients, while Cora's subscription structure includes ongoing provider availability without per-consultation surcharges.

B-vitamin additives: a meaningful pharmaceutical difference

Pomegranate Health's compounded semaglutide includes B12 (cyanocobalamin) as a standard additive, and compounded tirzepatide includes B6 (pyridoxine) as a standard additive. The B-vitamin enhancements are marketed as helping reduce nausea — a common GLP-1 side effect.

Cora Health's compounded medications are prepared without B-vitamin additives as the standard formulation. The pure compounded molecule (semaglutide or tirzepatide) is what patients receive.

For patients who want B-vitamin support to address nausea, Pomegranate's standard formulation may be appealing. For patients who prefer the closest possible formulation to the FDA-approved branded product (which does not contain added B-vitamins), Cora's pure compounded formulation may be preferable. Note that no large-scale clinical trials have evaluated B-vitamin-enhanced compounded GLP-1s for either efficacy or side-effect reduction. Compounded medications are not FDA-approved, and individual results vary.

Important compliance note on compounded products

Compounded semaglutide and compounded tirzepatide — obtained through Cora Health, Pomegranate Health, or any other telehealth provider — are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic, Wegovy, Mounjaro, Zepbound). The FDA does not review compounded medications for safety, effectiveness, or manufacturing quality before they reach patients. Clinical trial efficacy data (such as 14.9% mean weight loss in the STEP 1 trial for semaglutide and 22.5% in SURMOUNT-1 for tirzepatide) reflects studies of FDA-approved branded products without B-vitamin additives, not compounded versions. Individual results vary.

Pharmacy choice: single named partner vs multiple disclosed partners

A meaningful operational difference between the two platforms is the pharmacy partnership model.

Cora Health partners with a single compounding pharmacy — VialsRx, a US-licensed 503A facility — publicly named across the website. Every Cora patient receives medication prepared by VialsRx. Quality controls, batch consistency, and certificates of analysis come from one source.

Pomegranate Health discloses multiple pharmacy partners and offers patients the ability to choose among them. Disclosed partners include Hallandale, Empower, and OptioRx. Each pharmacy may have slightly different pricing, formulation specifics, and dispensing rules. The interactive pricing tool on Pomegranate's website allows patients to see actual monthly costs by pharmacy and dose before committing.

Both models are valid transparency approaches. The single-partner model offers consistency. The multi-partner model offers patient choice and price comparison. Patients with a preference should evaluate which model fits their priorities.

Geographic coverage: Cora 50 vs Pomegranate 47

Cora Health serves all 50 US states. Pomegranate Health is not available in California, Iowa, or Wisconsin as of May 2026 due to state-specific pharmacy or telehealth regulations. For patients in CA, IA, or WI, Pomegranate is not an option. For patients in any other US state, both platforms are geographically available.

Who should choose Cora Health

Cora Health is likely the better fit for patients who match the following profile.

• Cash-pay patients who want the lowest possible monthly cost on an annual commitment
• Patients who prefer one all-inclusive subscription with no separate consultation or refill fees
• Patients who want a single named compounding pharmacy partner (VialsRx)
• Patients who prefer the pure compounded molecule without B-vitamin additives
• Patients in any of the 50 US states (Cora ships nationwide)

Who should choose Pomegranate Health

Pomegranate Health is likely the better fit for patients who match the following profile.

• Patients who want pay-per-service flexibility without subscription auto-renewal
• Patients who specifically want B-vitamin additives (B12 with semaglutide, B6 with tirzepatide) for potential nausea support
• Patients who want to choose among multiple disclosed pharmacy partners
• Patients comfortable with the $75 consultation fee structure (initial + refills)
• Patients who want Klarna, Afterpay, or Affirm financing options
• Patients in any state except California, Iowa, or Wisconsin

Frequently asked questions

Common questions about the Cora Health vs Pomegranate Health comparison.

Is Cora Health cheaper than Pomegranate Health?

For a cash-pay patient on a 12-month treatment course, Cora's annual Essential Plan at $99/month ($1,188/year total) is approximately $300-$600 cheaper than Pomegranate's annualized cost ($119/mo × 12 + $75 initial + refill consultation fees = ~$1,500-$1,800/year). For compounded tirzepatide, Cora's annual Premium Plan at $135/month ($1,620/year) is approximately $500-$800 cheaper than Pomegranate ($179/mo × 12 + consultation fees = ~$2,200-$2,500/year).

Why does Pomegranate add B-vitamins to its compounded GLP-1s?

Pomegranate Health's standard compounded semaglutide formulation includes B12 (cyanocobalamin), and compounded tirzepatide includes B6 (pyridoxine). The B-vitamin additives are marketed as helping reduce nausea, a common GLP-1 side effect. No large-scale clinical trials have evaluated B-vitamin-enhanced compounded GLP-1s for either efficacy or side-effect reduction. The FDA-approved branded products (Wegovy, Zepbound) do not contain added B-vitamins. Cora Health's compounded medications are prepared without B-vitamin additives in the standard formulation.

Can I choose my own pharmacy at Pomegranate Health?

Yes. Pomegranate Health discloses multiple pharmacy partners (including Hallandale, Empower, and OptioRx) and offers patients an interactive pricing tool to see actual monthly costs by pharmacy and dose before committing. Each pharmacy may have slightly different pricing and formulation specifics. Cora Health uses a single named pharmacy partner (VialsRx) for all patients.

Can I use Cora Health if I live in California, Iowa, or Wisconsin?

Yes. Cora Health serves all 50 US states including California, Iowa, and Wisconsin. Pomegranate Health is not available in CA, IA, or WI as of May 2026.